$EVOH
EvoAir Holdings Inc. Stock $evoh

$evoh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224002428 Filed on January 16, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$41.17K	$49.97K	$142.7K
YoY Change	-41.94%	-64.98%	-82.36%
Cost Of Revenue	$87.08K	$100.3K	$162.9K
YoY Change	-2.09%	-38.4%	-76.98%
Gross Profit	-$45.91K	-$9.008K	-$20.17K
YoY Change	154.66%	-55.35%	-119.88%
Gross Profit Margin	-111.51%	-18.03%	-14.14%
Selling, General & Admin	$1.474M	$1.517M	$1.427M
YoY Change	3.29%	6.31%	179.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.081M	$95.37K	$35.13K
YoY Change	3.95%	171.51%
% of Gross Profit
Operating Expenses	$1.474M	$1.517M	$1.427M
YoY Change	3.29%	6.31%	179.76%
Operating Profit	-$1.520M	-$1.526M	-$1.447M
YoY Change	5.18%	5.45%	254.17%
Interest Expense	$40.00	$40.00	$6.00
YoY Change		566.67%
% of Operating Profit
Other Income/Expense, Net	$88.87K	$1.679K	$6.977K
YoY Change	1083.04%	-75.94%	-72.38%
Pretax Income	-$1.431M	-$1.524M	-$1.440M
YoY Change	-0.45%	5.85%	275.69%
Income Tax			$219.00
% Of Pretax Income
Net Earnings	-$1.367M	-$1.444M	-$1.373M
YoY Change	-0.67%	5.17%	258.26%
Net Earnings / Revenue	-3320.14%	-2890.26%	-962.49%
Basic Earnings Per Share	-$0.01	-$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	102.7M shares	102.7M shares	102.0M shares
Diluted Shares Outstanding	102.7M shares	102.6M shares	101.9M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$137.0K	$477.9K	$170.0K
YoY Change	-42.9%	181.11%
Cash & Equivalents	$137.0K	$477.9K	$166.2K
Short-Term Investments
Other Short-Term Assets	$47.13K	$122.4K
YoY Change
Inventory	$725.3K	$685.0K	$547.6K
Prepaid Expenses
Receivables	$42.69K	$51.62K	$67.66K
Other Receivables	$442.3K	$373.1K	$650.0K
Total Short-Term Assets	$1.394M	$1.710M	$1.430M
YoY Change	-7.36%	19.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$652.4K	$475.7K	$568.7K
YoY Change	20.89%	-16.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$74.79M	$75.91M	$80.32M
YoY Change	-5.52%	-5.49%
TOTAL ASSETS
Total Short-Term Assets	$1.394M	$1.710M	$1.430M
Total Long-Term Assets	$74.79M	$75.91M	$80.32M
Total Assets	$76.19M	$77.62M	$81.75M
YoY Change	-5.55%	-5.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$214.3K	$233.0K	$46.95K
YoY Change	248.02%	396.2%	369.49%
Accrued Expenses	$127.3K	$144.6K	$87.84K
YoY Change	154.75%	64.62%	631.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.216M	$1.193M	$727.0K
YoY Change	22.2%	64.1%	1172.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$159.2K	$186.9K	$330.0K
YoY Change	-41.05%	-43.38%
Total Long-Term Liabilities	$159.2K	$186.8K	$333.3K
YoY Change	-41.34%	-43.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.216M	$1.193M	$727.0K
Total Long-Term Liabilities	$159.2K	$186.8K	$333.3K
Total Liabilities	$1.078M	$1.380M	$1.060M
YoY Change	-14.88%	30.14%	1755.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.33M	-$14.97M	-$8.839M
YoY Change	59.91%	69.34%
Common Stock	$91.54M	$91.54M	$89.60M
YoY Change	2.16%	2.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$75.11M	$76.47M	$80.82M
YoY Change
Total Liabilities & Shareholders Equity	$76.19M	$77.62M	$81.75M
YoY Change	-5.55%	-5.05%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.367M	-$1.444M	-$1.373M
YoY Change	-0.67%	5.17%	258.26%
Depreciation, Depletion And Amortization	$1.081M	$95.37K	$35.13K
YoY Change	3.95%	171.51%
Cash From Operating Activities	-$354.1K	-$103.5K	-$264.2K
YoY Change	405.91%	-60.84%
INVESTING ACTIVITIES
Capital Expenditures	-$11.54K	$107.7K	$1.044K
YoY Change	-215.4%	10218.49%	-99.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$11.54K	-$107.7K	-$1.044K
YoY Change	-215.4%	10218.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.170K	-$1.972K	$297.1K
YoY Change	-101.55%	-100.66%
NET CHANGE
Cash From Operating Activities	-354.1K	-$103.5K	-$264.2K
Cash From Investing Activities	11.54K	-$107.7K	-$1.044K
Cash From Financing Activities	-2.170K	-$1.972K	$297.1K
Net Change In Cash	-344.8K	-$213.2K	$31.83K
YoY Change	-674.62%	-769.71%
FREE CASH FLOW
Cash From Operating Activities	-$354.1K	-$103.5K	-$264.2K
Capital Expenditures	-$11.54K	$107.7K	$1.044K
Free Cash Flow	-$342.6K	-$211.2K	-$265.3K
YoY Change	328.25%	-20.38%	-47.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001700844
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q4	us-gaap	Increase Decrease In Due To Officers And Stockholders IncreaseDecreaseInDueToOfficersAndStockholders		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	EVOH	Lessee Operating Lease Liability Payments Due After Year Three LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-11-30
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	333-228161
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	EvoAir Holdings Inc.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1353613
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	31-A2, Jalan 5/32A
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	6 ½ Miles
CY2023Q4	dei	Entity Address Address Line3 EntityAddressAddressLine3	Off Jalan
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Kepong
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	52000
CY2023Q4	dei	Entity Address Country EntityAddressCountry	MY
CY2023Q4	dei	City Area Code CityAreaCode	603
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	6243 3379
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102742362	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	477885	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	779049	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51620	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44130	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	685006	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	630478	usd
CY2023Q4	EVOH	Deposit Prepayments And Other Receivables DepositPrepaymentsAndOtherReceivables	495450	usd
CY2023Q3	EVOH	Deposit Prepayments And Other Receivables DepositPrepaymentsAndOtherReceivables	617507	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1709961	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2071164	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	475743	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463387	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253431	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	271021	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	75179439	usd
CY2023Q3	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	76218786	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	75908613	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	76953194	usd
CY2023Q4	us-gaap	Assets Assets	77618574	usd
CY2023Q3	us-gaap	Assets Assets	79024358	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	289637	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	170888	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	19100	usd
CY2023Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	27487	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	390083	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	440069	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	7548	usd
CY2023Q3	us-gaap	Purchase Obligation PurchaseObligation	9224	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	398747	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	232095	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87912	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	84879	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1193027	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	964642	usd
CY2023Q4	EVOH	Noncurrent Hire Purchase Creditor NoncurrentHirePurchaseCreditor	10235	usd
CY2023Q3	EVOH	Noncurrent Hire Purchase Creditor NoncurrentHirePurchaseCreditor	10531	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	176612	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	198163	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	186847	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	208694	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1379874	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1173336	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102742362	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102742362	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102310933	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102310933	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	102742	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	102311	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	91436762	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	90371141	usd
CY2023Q3	EVOH	Shares To Be Issued SharesToBeIssued	1066052	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-102244	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17036	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14967589	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13523266	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-230971	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-148180	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76238700	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77851022	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77618574	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79024358	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	91318	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	142685	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	100326	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	162858	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	-9008	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	-20173	usd
CY2023Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	33003	usd
CY2022Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3565	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1483989	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1423382	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	1516992	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	1426947	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1526000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1447120	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	40	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6	usd
CY2023Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1639	usd
CY2022Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6983	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1679	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6977	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1524321	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1440143	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	219	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-1524321	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1440362	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79998	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-67035	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1444323	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1373327	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88001	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-17907	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1532324	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1391234	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2793	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4184	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1529531	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1387050	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102623762	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102623762	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101868154	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101868154	shares
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	81844479	usd
CY2022Q4	EVOH	Adjustments To Additional Paid In Capital Capital Contribution AdjustmentsToAdditionalPaidInCapitalCapitalContribution	100	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	299055	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	17907	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1440362	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80685365	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77851022	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77851022	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	88001	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-1524321	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76238700	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76238700	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-1524321	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1440362	usd
CY2023Q4	us-gaap	Depreciation Depreciation	95369	usd
CY2022Q4	us-gaap	Depreciation Depreciation	35126	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1039347	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1065646	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7490	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18303	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	54528	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-71438	usd
CY2023Q4	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-122057	usd
CY2022Q4	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-183110	usd
CY2023Q4	EVOH	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	-17590	usd
CY2022Q4	EVOH	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	-5553	usd
CY2023Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	118749	usd
CY2022Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-82046	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-49986	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-79530	usd
CY2023Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-18518	usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-30785	usd
CY2023Q4	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-8387	usd
CY2022Q4	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-10669	usd
CY2023Q4	us-gaap	Increase Decrease In Due To Officers And Stockholders IncreaseDecreaseInDueToOfficersAndStockholders	166652	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-103466	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-264216	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107725	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1044	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-107725	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1044	usd
CY2023Q4	EVOH	Payments To Hire Purchase PaymentsToHirePurchase	1972	usd
CY2022Q4	EVOH	Payments To Hire Purchase PaymentsToHirePurchase	2066	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	299055	usd
CY2022Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	100	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1972	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	297089	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-213163	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	31829	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-88001	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-17907	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	779049	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	152304	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	477885	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	166226	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101779323	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101779323	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14967589	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13523266	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-1524321	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-1440362	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-103466	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-264216	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zSub556Oq0Jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_869_zsMGedi9XA85">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales and expenses during the reporting periods. Key estimates in the accompanying consolidated financial statements include, among others, revenue recognition, allowances for doubtful accounts and product returns, provisions for obsolete inventory, valuation of long-lived assets and Rights of Use (“ROU”) assets (including lease liabilities), and deferred income tax asset valuation allowances. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_849_eus-gaap--FiscalPeriod_zvhym6y0nVHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_867_zsffHJBUE3e2">Fiscal Year End</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company operates on a fiscal year basis with the fiscal year ending on August 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51620	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44130	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	440069	usd
CY2023Q4	us-gaap	Revenues Revenues	49972	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	390083	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	296717	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	329420	usd
CY2023Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	157704	usd
CY2023Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	138869	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	230585	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	162189	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	685006	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	630478	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	122364	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	20777	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	373086	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	596730	usd
CY2023Q4	EVOH	Deposit Prepayments And Other Receivables DepositPrepaymentsAndOtherReceivables	495450	usd
CY2023Q3	EVOH	Deposit Prepayments And Other Receivables DepositPrepaymentsAndOtherReceivables	617507	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	852879	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	745154	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	377136	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	281767	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	475743	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463387	usd
CY2022Q4	us-gaap	Depreciation Depreciation	35126	usd
CY2023Q4	us-gaap	Depreciation Depreciation	95369	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	83147767	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	83147767	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7968328	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6928981	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75179439	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	76218786	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1039347	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1065646	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	232964	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	40939	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	56673	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	129949	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	19100	usd
CY2022Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	27487	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	308737	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	198375	usd
CY2023Q4	us-gaap	Short Term Debt Terms ShortTermDebtTerms	Amounts due to shareholders are unsecured, with interest of 3% per annum and tenure of 6 months, or mutually between the parties
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	398747	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	232095	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	30000	shares
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75000	usd
CY2022Q4	EVOH	Number Of Shares To Be Issued NumberOfSharesToBeIssued	0	shares
CY2022Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	100	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	373822	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.50
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	934534	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102742362	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102742362	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102310933	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102310933	shares
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.21	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14960000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13520000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14960000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13520000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14960000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13520000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253431	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	271021	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87912	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	84879	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	176612	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	198163	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	264524	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	283042	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	87912	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	94376	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	66212	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16024	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	264524	usd

Files In Submission

Name	View Source	Status
evoh-20231130_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
evoh-20231130_pre.xml	Edgar Link	unprocessable
0001493152-24-002428-index-headers.html	Edgar Link	pending
0001493152-24-002428-index.html	Edgar Link	pending
0001493152-24-002428.txt	Edgar Link	pending
0001493152-24-002428-xbrl.zip	Edgar Link	pending
evoh-20231130.xsd	Edgar Link	pending
evoh-20231130_cal.xml	Edgar Link	unprocessable
evoh-20231130_def.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVOH
EvoAir Holdings Inc. Stock $evoh

2024 Q1 Form 10-Q Financial Statement

#000149315224002428 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVOH EvoAir Holdings Inc. Stock $evoh

2024 Q1 Form 10-Q Financial Statement

#000149315224002428 Filed on January 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVOH
EvoAir Holdings Inc. Stock $evoh